Clinical-Grade Devices

Before diabetes arrives, there is a window. The CDC estimates 96 million American adults have pre-diabetes, and most of them do not know it. A digital program with more clinical evidence than any competitor is designed to close that window before it opens into disease. The Diabetes Prevention Program (DPP), a landmark clinical trial conducted…

Managing diabetes has always required more than a glucose number. The challenge is integrating blood sugar data with the behavioral, nutritional, and emotional factors that determine long-term outcomes. A 2023 study published in Diabetes Care by the American Diabetes Association found that only 21% of adults with type 2 diabetes in the United States achieve…

When a home sleep test needs to measure what polysomnography measures, the Nox T3 bridges the gap between laboratory precision and home convenience. The debate over how much diagnostic data is “enough” for sleep apnea diagnosis has shaped clinical sleep medicine for over two decades. On one end, full polysomnography captures 20 to 46 channels…

An estimated 80% of moderate to severe obstructive sleep apnea cases remain undiagnosed. A wrist-worn device that requires no nasal cannula is changing the diagnostic calculus. Sleep apnea is one of the most consequential yet underdiagnosed conditions in modern medicine. A 2019 analysis published in The Lancet Respiratory Medicine estimated that 936 million adults worldwide…

Every night, roughly 70 million Americans struggle with a sleep disorder, yet the diagnostic gold standard for unraveling what happens in their brains after lights out has remained fundamentally the same for decades: polysomnography. A 2023 review published in The Lancet Respiratory Medicine by Benjafield et al. estimated that nearly one billion adults worldwide have…

For three decades, one wrist-worn device has defined how researchers measure sleep, light exposure, and circadian rhythms in clinical studies worldwide. A 2022 meta-analysis published in Sleep Medicine Reviews by Sadeh analyzed data from over 150 studies using actigraphy to assess sleep and circadian function. The analysis confirmed what sleep researchers had known for years:…

The company that wrote the book on pulse oximetry accuracy brings hospital-grade oxygen monitoring to a wrist-worn form factor for the first time. In the early months of the COVID-19 pandemic, a quiet crisis unfolded in emergency departments worldwide. Patients arriving with critically low blood oxygen levels, sometimes below 70%, reported feeling only mildly short…

The first FDA-cleared cuffless blood pressure monitor designed for hospital and remote patient monitoring brings continuous hemodynamic surveillance to patients who need it most. Blood pressure is measured billions of times each year in clinical settings worldwide, yet the fundamental technology has barely changed in over a century. An inflatable cuff occludes arterial blood flow,…

When a two-week cardiac monitor is not enough, the BioTelemetry MCOT Patch extends the diagnostic window to 30 continuous days of real-time ECG surveillance. In 2019, a landmark study published in the Journal of the American Heart Association analyzed over 90,000 patients monitored with mobile cardiac outpatient telemetry and found that extending monitoring duration beyond…

Atrial fibrillation is the most common cardiac arrhythmia, affecting an estimated 6 million Americans, but its intermittent nature means that traditional 24 to 48 hour Holter monitors miss the majority of episodes. A 14-day continuous ECG patch, analyzed by artificial intelligence, fundamentally changes the diagnostic yield. Cardiac arrhythmias are, by nature, elusive. A patient experiences…